Compliance & EnforcementFalse Claims Act
ArchiveFalse Claims Act
3,592 articles from the Compliance & Enforcement Brief.
Articles
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.
The False Claims Act in 2019: A Government Enforcement Update
Relators Hit Public Disclosure Bar by Referencing Government Audit Mirroring Their Allegations; United States District Court for the District of Columbia No. 13-1844 (CKK), U.S. ex rel. Patricia Scott and John L. Tudbury v. Pacific Architect Engineers Inc.
White Collar Year in Preview: False Claims Act Trends in 2020
DOJ Rings in the New Year With FY2019 FCA Stats Release, Announcing $3 Billion in FCA Recoveries
Raytheon Cannot Cite “Government Interests” in Moving to Dismiss Whistleblower Retaliation Complaint; United States District Court for the Northern District of Texas, Dallas Division, No. 3:17-CV-1098-D, U.S. ex rel. Dana Johnson v. Raytheon Company
Jury Reasonably Weighed Competing Testimony Before Awarding Plaintiff Compensation for Unlawful Retaliation; United States District Court for the District of Massachusetts No. 11-12131-RWZ, U.S. ex rel. Kimberly Herman, Amy Lestage and Kevin Roseff v. Coloplast Corp., et al.
Let’s Talk FCA: Resolving False Claims Act Disputes (January 2020)
Fastest 5 Minutes: ITAR, FCA, Bid Protest News (January 17)
Individual Defendant Cannot Duck Responsibility for False Claims Submitted by His Company Through Kickback Scheme; United States District Court for the Western Division of Texas, El Paso Division, No. EP-18-CV-193-KC, U.S. ex rel. Susann Campbell v. KIC Development LLC, RECA Construction LLC, Anthony Acri, Christine Hayes, Earl Hall, and James G. Tuskan
Fraudulent Billing to Private Insurer Alone Does Not Create Strong Inference False Claims Were Submitted to Medicare; United States District Court for the Central District of California, No. CV 17-8446 PSG (JPRx), U.S. ex rel. Charles Puhl et al. v. Terumo BCT et al.
False Claims Act: 2019 Year-in-Review
The FCA Continues to Pay (For the Government): Key Takeaways from DOJ’s FY 2019 Fraud Statistics
Resmed Corp. to Pay the United States $37.5 Million for Allegedly Causing False Claims Related to the Sale of Equipment for Sleep Apnea and Other Sleep-Related Disorders
Unlawful Retaliation Only One of Several Factors Leading to Relator’s Termination; United States Court of Appeal for the Eleventh Circuit No. 18-14484, Jamie Nesbitt v. Candler County, Georgia
Failure to Connect Conduct to False Claims Fatal to Qui Tam Complaint; United States District Court for the District of New Jersey No. 13-3962, U.S. ex rel. Chunyan Cao v. West-Ward Pharmaceuticals and Hikma Pharmaceuticals PLC
Requirement to Bill Liable Third Parties Before State Medicaid Program Material to State’s Decision to Pay; U.S. District Court for the Southern District of New York No. 10 Civ. 9650 (RMB) (GWG), U.S. ex rel. June Raffington v. Bon Secours Health System Inc., et al.
Amount of Financial Recovery Has No Bearing on Award of Attorneys’ Fees in Successful Qui Tam Case; U.S. District Court for the District of Kansas No. 16-2034-CM-JPO, U.S. ex rel. Bashar Sean Awad and Cynthia McKerrigan v. Coffey Health System
Normal Business Dealings Insufficient to Show Conspiracy to Avoid Anti-Dumping Duties; U.S. District Court for the Central District of California No. 2:17-cv-04393-RGK-KS, United States v. Vandewater International Inc., et al.
Court Declines to Stay FCA Case Pending Outcome of Appeal to Court of International Trade; U.S. District Court for the Central District of California No. 2:17-cv-04393-RGK-KS, United States v. Vandewater International Inc., et al.
Keep reading
